pyridoxine has been researched along with hydralazine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gilgore, GS; Schleifer, CR; Sigler, MH; Smith, LJ; Teehan, BP | 1 |
Vidrio, H | 1 |
Fishman, RA; Raskin, NH | 1 |
Kuchel, O; Shigetomi, S | 1 |
Khan, RA; Siddiqui, AA; Tauqeer, S | 1 |
1 review(s) available for pyridoxine and hydralazine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for pyridoxine and hydralazine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Plasma pyridoxal-5'-phosphate levels and clinical correlations in chronic hemodialysis patients.
Topics: Adult; Humans; Hydralazine; Pyridoxal Phosphate; Pyridoxine; Renal Dialysis; Uremia; Vitamin B 6 Deficiency | 1978 |
Interaction with pyridoxal as a possible mechanism of hydralazine hypotension.
Topics: Anesthesia; Animals; Blood Pressure; Cinnarizine; Dose-Response Relationship, Drug; Hydralazine; Injections, Intraperitoneal; Isoniazid; Male; Pyridoxal; Pyridoxine; Rats; Rats, Inbred Strains; Vasodilator Agents; Verapamil | 1990 |
Pyridoxine-deficiency neuropathy due to hydralazine.
Topics: Female; Humans; Hydralazine; Hypertension; Middle Aged; Paresthesia; Pyridoxine; Tryptophan; Urine; Vitamin B 6 Deficiency; Xanthurenates | 1965 |
Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Topics: Adult; Cardiovascular System; Decarboxylation; Dihydroxyphenylalanine; Diuresis; Dopamine; Female; Hormones; Humans; Hydralazine; Hypertension; Kidney; Levodopa; Male; Middle Aged; Pyridoxine; Sodium | 1993 |
Evaluation of teratogenic effects of risperidone following simultaneous administration with antihypertensive and antiemetic drugs.
Topics: Abnormalities, Drug-Induced; alpha-Tocopherol; Animals; Antiemetics; Antihypertensive Agents; Drug Evaluation, Preclinical; Drug Interactions; Female; Fetal Weight; Hydralazine; Meclizine; Mice; Pyridoxine; Risperidone; Stillbirth | 2012 |